LIGAND PHARMACEUTICALS INCORPORATED Derivative Asset, Current
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) had Derivative Asset, Current of $923.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DerivativeAssetsCurrent · last filed 2026-08-07
- 2026-06-30: Derivative Asset, Current $923.00K.
- 2026-03-31: Derivative Asset, Current $1.27M.
- 2025-12-31: Derivative Asset, Current $0.00.
- 2024-09-30: Derivative Asset, Current $11.13M.
| Period end | Derivative Asset, Current |
|---|---|
| 2026-06-30 | $923.00K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $1.27M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-07 |
| 2024-09-30 | $11.13M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $20.14M 10-Q · filed 2024-08-07 |
| 2023-12-31 | $0.00 10-Q · filed 2024-11-08 |
| 2019-12-31 | $0.00 10-K · filed 2020-02-27 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-08 |
| 2019-06-30 | $14.31M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $18.72M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $22.58M 10-K · filed 2020-02-27 |
| 2018-09-30 | $509.26M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $399.41M 10-Q · filed 2018-08-08 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-28 |